Clinical profiles and outcomes in idiopathic duct-centric chronic pancreatitis (type 2 autoimmune pancreatitis): the Mayo Clinic experience

Published on Oct 1, 2016in Gut19.819
· DOI :10.1136/GUTJNL-2015-309275
Phil A. Hart29
Estimated H-index: 29
(Mayo Clinic),
Michael J. Levy107
Estimated H-index: 107
(Mayo Clinic)
+ 10 AuthorsSuresh T. Chari103
Estimated H-index: 103
(Mayo Clinic)
Sources
Abstract
Objective Idiopathic duct-centric chronic pancreatitis (IDCP), also known as type 2 autoimmune pancreatitis (AIP), is an uncommon subtype of AIP. International Consensus Diagnostic Criteria for IDCP propose that the diagnosis requires pancreatic histology and/or concurrent IBD. We examined our experience with IDCP (type 2 AIP) to assess the appropriateness of these criteria, and identify unique characteristics in patients presenting with acute pancreatitis. Design We reviewed the Mayo Clinic AIP database through May 2014 to identify subjects with either definitive (n=31) or probable (n=12) IDCP. We compared demographic and clinical factors based on strength of diagnostic confidence (definitive versus probable), presence of IBD, and acute pancreatitis as the presenting manifestation. Relapse-free survival was determined using the Kaplan-Meier method. Results The clinical profiles were similar irrespective of the diagnostic criteria fulfilled. Common clinical presentations included acute pancreatitis (n=25, 58.1%, 12 of whom (27.9%) had recurrent pancreatitis) and pancreatic mass/obstructive jaundice (n=15, 34.9%). The cumulative relapse rate was 10.6% at 3 years (median follow-up 2.9 years). Relapse-free survival was similar for the different diagnostic categories, but was decreased in those initially presenting with acute pancreatitis (p=0.047) or treated with steroids (vs surgery, p=0.049). Conclusions The current diagnostic classification of probable IDCP and the inclusion of IBD as a supportive criterion appear valid, because patients have similar clinical profiles and disease-related outcomes to those with definitive IDCP. Concurrent IBD, especially in young patients, may suggest when IDCP is the underlying cause of recurrent acute pancreatitis, but additional studies are needed for validation.
📖 Papers frequently viewed together
20112.92Pancreas
14 Authors (Tooru Shimosegawa, ..., Lizhi Zhang)
948 Citations
316 Citations
201319.82Gut
25 Authors (Phil A. Hart, ..., Suresh T. Chari)
343 Citations
References15
Newest
#1Atsushi Kanno (Kansai Medical University)H-Index: 39
#1Atsushi Kanno (Kansai Medical University)H-Index: 18
Last. Tooru ShimosegawaH-Index: 95
view all 8 authors...
OBJECTIVES: To clarify the clinicoepidemiological features of autoimmune pancreatitis (AIP) in Japan, a nationwide epidemiological survey was conducted. METHODS: Patients with AIP who had visited selected hospitals in 2011 were surveyed. Autoimmune pancreatitis was diagnosed according to the revised clinical diagnostic criteria for AIP (Japan Pancreas Society 2011). The study consisted of 2 stage surveys; the number of patients with AIP was estimated by the first questionnaire, and their clinica...
91 CitationsSource
#1Phil A. Hart (Mayo Clinic)H-Index: 29
#2Terumi Kamisawa (Tokyo Metropolitan Komagome Hospital)H-Index: 77
Last. Suresh T. Chari (Mayo Clinic)H-Index: 103
view all 25 authors...
Objective Autoimmune pancreatitis (AIP) is a treatable form of chronic pancreatitis that has been increasingly recognised over the last decade. We set out to better understand the current burden of AIP at several academic institutions diagnosed using the International Consensus Diagnostic Criteria, and to describe long-term outcomes, including organs involved, treatments, relapse frequency and long-term sequelae. Design 23 institutions from 10 different countries participated in this multination...
343 CitationsSource
#1Phil A. Hart (Mayo Clinic)H-Index: 29
#2Mark Topazian (Mayo Clinic)H-Index: 65
Last. Suresh T. Chari (Mayo Clinic)H-Index: 103
view all 14 authors...
Background There is a paucity of data on long-term management of type 1 autoimmune pancreatitis (AIP), a relapsing steroid-responsive disorder. Objective We describe our experience with treatment of relapses and maintenance of remission using steroid-sparing immunomodulators (IMs) and induction of remission using rituximab (RTX). Methods We obtained details of disease relapse and treatment in 116 type 1 AIP patients from clinic visits, medical records and telephone interviews. We compared relaps...
254 CitationsSource
#1Scott Tenner (SUNY Downstate Medical Center)H-Index: 2
#2John BaillieH-Index: 48
Last. Santhi Swaroop Vege (Mayo Clinic)H-Index: 50
view all 4 authors...
This guideline presents recommendations for the management of patients with acute pancreatitis (AP). During the past decade, there have been new understandings and developments in the diagnosis, etiology, and early and late management of the disease. As the diagnosis of AP is most often established by clinical symptoms and laboratory testing, contrast-enhanced computed tomography (CECT) and / or magnetic resonance imaging (MRI) of the pancreas should be reserved for patients in whom the diagnosi...
1,089 CitationsSource
#1Terumi Kamisawa (Tokyo Metropolitan Komagome Hospital)H-Index: 77
#2Suresh T. Chari (Mayo Clinic)H-Index: 103
Last. Tooru Shimosegawa (Tohoku University)H-Index: 95
view all 6 authors...
Autoimmune pancreatitis (AIP) is a form of chronic pancreatitis characterised clinically by frequent presentation with obstructive jaundice, histologically by a lymphoplasmacytic infiltrate with fibrosis, and therapeutically by a dramatic response to steroids. When so defined, AIP can be sub-classified into two subtypes, 1 and 2. Recent international consensus diagnostic criteria for AIP have been developed for diagnosis of both forms of AIP. Type 1 AIP is the pancreatic manifestation of a multi...
119 CitationsSource
#1Sang Hyoung Park (UOU: University of Ulsan)H-Index: 27
#2Donghoi KimH-Index: 3
Last. Jin Ho KimH-Index: 23
view all 12 authors...
Results: Of the 104 patients with AIP, 6 (5.8%) were also diagnosed with UC. Serum immunoglobulin G (IgG) and IgG4 were elevated in 1 patient (16.7%), respectively, and 4 (66.7%) showed idiopathic duct-centric pancreatitis (type 2 AIP). Compared with 24 matched patients with UC only, AIP-UC patients had a lower body mass index (P=0.003), higher C-reactive protein levels (P=0.048), and higher Mayo scores (P=0.006) at diagnosis of UC. Two AIP-UC patients (33.3%), but none with UC only showed incre...
30 CitationsSource
#1Terumi Kamisawa (Tokyo Metropolitan Komagome Hospital)H-Index: 77
#2Suresh T. ChariH-Index: 103
Last. Vay Liang W. Go (UCLA: University of California, Los Angeles)H-Index: 93
view all 22 authors...
: The objective of this study was to clarify the clinical and pathophysiological characteristics of autoimmune pancreatitis (AIP) and its subtypes (lymphoplasmacytic sclerosing pancreatitis [LPSP] and idiopathic duct-centric pancreatitis [IDCP]) seen around the world.: An international multicenter survey of AIP was conducted in 15 institutes from 8 countries. We compared clinical and pathologic profiles of AIP (n = 731) and the clinical profiles of LPSP (n = 204) and IDCP (n = 64) patients.: Pat...
187 CitationsSource
#1Tooru Shimosegawa (Tohoku University)H-Index: 95
#2Suresh T. ChariH-Index: 103
Last. Lizhi ZhangH-Index: 54
view all 14 authors...
Objectives:To achieve the goal of developing international consensus diagnostic criteria (ICDC) for autoimmune pancreatitis (AIP).Methods:An international panel of experts met during the 14th Congress of the International Association of Pancreatology held in Fukuoka, Japan, from July 11 through 13,
948 CitationsSource
#1Raghuwansh P. Sah (Mayo Clinic)H-Index: 20
#2Suresh T. Chari (Mayo Clinic)H-Index: 103
Last. Santhi Swaroop Vege (Mayo Clinic)H-Index: 50
view all 13 authors...
Background & Aims Autoimmune pancreatitis (AIP) has been divided into subtypes 1 (lymphoplasmacytic sclerosing pancreatitis) and 2 (idiopathic duct centric pancreatitis). We compared clinical profiles and long-term outcomes of types 1 and 2 AIP. Methods We compared clinical presentation, relapse, and vital status of 78 patients with type 1 AIP who met the original HISORt criteria and 19 patients with histologically confirmed type 2 AIP. Results At presentation, patients with type 1 AIP were olde...
316 CitationsSource
#1Raghuwansh P. Sah (Mayo Clinic)H-Index: 20
#2Rahul Pannala (Mayo Clinic)H-Index: 21
Last. Santhi Swaroop Vege (Mayo Clinic)H-Index: 50
view all 12 authors...
Background & Aims Little is known about how many patients with features of acute pancreatitis (AP) or chronic pancreatitis (CP) have autoimmune pancreatitis (AIP); most information comes from case reports. We explored the clinical profiles and relationship between these diseases. Methods We evaluated 178 patients presenting to our Pancreas Clinic between January 2005 and June 2006 for evaluation of the etiology of their suspected pancreatitis; AIP was diagnosed when patients met HISORt ( H istol...
57 CitationsSource
Cited By38
Newest
#1Yoshiharu Masaki (Sapporo Medical University)H-Index: 7
#2Hiroshi Nakase (Sapporo Medical University)H-Index: 48
Last. Yuzo Kodama (Kobe University)H-Index: 35
view all 14 authors...
The effectiveness of azathioprine (AZA) in preventing relapse and maintaining autoimmune pancreatitis (AIP) remission has been reported; however, most of these studies are case series with no randomized control trials available in the literature. Therefore, this study performed a systematic review and meta-analysis of the existing literature on this subject to determine the clinical efficacy of AZA as maintenance therapy for AIP patients. A systematic search was performed to identify studies on ...
Source
Last. Kam A. Newman (UCR: University of California, Riverside)H-Index: 9
view all 5 authors...
Source
#1Nicolò de PretisH-Index: 8
#2Antonio AmodioH-Index: 13
Last. Luca FrulloniH-Index: 11
view all 3 authors...
Source
#1Krishna Pattabathula (Royal Brisbane and Women's Hospital)
#1Krishna Pattabathula (Royal Brisbane and Women's Hospital)
Last. Nicholas O'Rourke (UQ: University of Queensland)H-Index: 24
view all 8 authors...
BACKGROUND Autoimmune processes are now an increasingly recognized cause of acute and chronic pancreatitis. Autoimmune pancreatitis is a rare, benign pathology with two distinct clinicopathologic subtypes. The aim of this study was to compare the presentation, diagnostic considerations and outcomes of patients with biopsy-proven type 1 and 2 autoimmune pancreatitis (AIP). METHODS A retrospective review of the Queensland Health pathology database of histologically proven AIP was conducted. Parame...
Source
#1Antonio Facciorusso (University of Foggia)H-Index: 19
#2Luca Barresi (ISMETT)H-Index: 22
Last. Sachin Wani (Anschutz Medical Campus)H-Index: 68
view all 9 authors...
Background and study aims There is limited evidence on the diagnostic performance of endoscopic ultrasound (EUS)-guided tissue acquisition in autoimmune pancreatitis (AIP). The aim of this meta-analysis was to provide a pooled estimate of the diagnostic performance of EUS-guided fine-needle aspiration (FNA) and fine-needle biopsy (FNB) in patients with AIP. Patients and methods Computerized bibliographic search was performed through January 2020. Pooled effects were calculated using a random-eff...
2 CitationsSource
#1Takuya Ishikawa (Nagoya University)H-Index: 14
#2Hiroki Kawashima (Nagoya University)H-Index: 27
Last. Mitsuhiro Fujishiro (Nagoya University)H-Index: 64
view all 14 authors...
BACKGROUND AND AIM We examined the differences in the risks and characteristics of pancreatic relapse (PR) and pancreatic cancer (PC) in patients with autoimmune pancreatitis (AIP). METHODS We retrospectively reviewed 123 type 1 AIP patients with a median follow-up of 55 months (interquartile range, 27-98). The following items were evaluated: 1) cumulative relapse rates and risk factors, 2) the incidence of PC, 3) PR versus PC, and 4) outcomes after the appearance of morphological changes in the...
5 CitationsSource
#1Sönke Detlefsen (University of Southern Denmark)H-Index: 21
#2Søren Schou Olesen (AAU: Aalborg University)H-Index: 28
Abstract Autoimmune pancreatitis (AIP) is a distinct form of chronic pancreatitis that has been increasingly recognised over the last decades and shows a good response to corticosteroid treatment. Two different forms of AIP have been characterized. Type 1 AIP is the pancreatic manifestation of IgG4-related disease and often affects multiple organ systems. In contrast, type 2 AIP is confined to the pancreas and involvement of extra-pancreatic organs has previously only very rarely been reported, ...
Source
PURPOSE OF REVIEW Type 2 autoimmune pancreatitis (AIP) is a rare inflammatory disease of the pancreas. Very few data have been published on this particular subtype, which differs from the 'classical' IgG4-related type 1 AIP in terms of pathological features, epidemiology and risk of relapse. The aim of the current review is to summarize the available literature, suggesting a diagnostic and therapeutic approach to this disease. RECENT FINDINGS Based on the International Consensus Diagnostic Crite...
2 CitationsSource
#1Mario Pelaez-Luna (UNAM: National Autonomous University of Mexico)H-Index: 17
Last. L.F. Uscanga-DomínguezH-Index: 7
view all 4 authors...
Autoimmune pancreatitis has received considerable attention, especially due to the marked effect of corticosteroid therapy on its clinical course. Knowledge, especially regarding type 1 autoimmune pancreatitis, has significantly increased over the last decades, and despite significant differences in pathophysiology and outcomes, both type 1 and 2 autoimmune pancreatitis are still considered different types of the same disease. Some have proposed a different nomenclature reflecting these differen...
Source
#1Lina Chen (Queen's University)
#2Christine Elizabeth Orr (Queen's University)H-Index: 1
Last. Tao Wang (Queen's University)
view all 3 authors...
INTRODUCTION Type 1 and type 2 autoimmune pancreatitis (AIP) can mimic pancreatic neoplasia. Due to the small quantity of tissue in mass-targeted pancreas biopsies, inflammatory features may raise the differential of AIP. However, the frequency of AIP-like histology in neoplastic pancreas is not well characterized. Therefore, the specificity of inflammatory lesions on biopsy with respect to the diagnosis of AIP is uncertain. MATERIALS AND METHODS Neoplastic pancreas resections performed at our i...
1 CitationsSource